ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1400 participants.
Also called NCT02910089
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 1,400 participants
- Sponsor
- Registry
-
NCT02910089
-
- Other papers using this trial's data
- Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02910089. Randomized; no masking; primary purpose other. Start 2016-10-20 (actual); primary completion 2017-12-20 (actual). Results posted on 2019-08-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
- Acronym
- ENGAGE-DM
- Condition
- Diabetes Mellitus Type 2
- Intervention (Behavioral)
- Shared Decision Making
- Lead sponsor
- AstraZeneca
- Collaborator
- Brigham Women's Health
Record details
- Record id
cardio:ct-nct02910089- Content hash
4ef614a84d03ba8ca62abd70ff9f825e3c1ef5277799b92ab46ea2b4a83630bd